NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis

Zimmer Biomet Holdings, Inc. (ZBH) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

ZBH

$98.07

−$0.85 (−0.86%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ZBH with… →

ZBH Key Statistics

As of Sep 4, 2026
Trading
Open
$97.77
Previous Close
$98.92
Day's Range
96.84–98.77
52-Week Range
79.12–106.88
Volume
1.32M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.47
Valuation
Market Cap
$18.71B
P/E Ratio
24.04
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
10.82
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.62
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.20
EPS (ttm)Profit attributable to each share over the last twelve months.
4.08
Financials (FY)
Revenue (FY)
$8.23B+7.20%
Net Income (FY)
$705.10M−21.98%
Profit marginThe share of revenue left as profit after all costs and taxes.
9.48%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
190.74M
1-Year Return
−5.40%
Dividend and dates
Dividend
$0.96+0.97%
Ex-Dividend Date
September 30, 2026
Earnings Date
November 5, 2026
Avg Volume
2.19M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ZBH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+9.65%
2025−14.03%
2024−12.46%
2023−3.81%
2022+4.24%
2021−17.02%
2020+3.77%
2019+45.37%
2018−13.30%
2017+17.86%
2016 (partial year)−21.28%

As of September 4, 2026.

ZBH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$8.23B$705.10M8.6%
2024$7.68B$903.80M11.8%
2023$7.39B$1.02B13.8%
2022$6.94B$231.40M3.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$8.23B$5.74B$1.36B$705.10M8.6%
2024$7.68B$5.49B$1.53B$903.80M11.8%
2023$7.39B$5.31B$1.45B$1.02B13.8%
2022$6.94B$4.92B$1.19B$231.40M3.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ZBH Dividend History

$0.96+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.482—
2025$0.964+0.0%
2024$0.964+0.0%
2023$0.964+0.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.482—
2025$0.964+0.0%
2024$0.964+0.0%
2023$0.964+0.0%
2022$0.964+3.0%
2021$0.934+0.0%
2020$0.934+0.0%
2019$0.934+0.0%
2018$0.934+0.0%
2017$0.934+100.0%
2016$0.472—

Most recent payment: $0.24 per share, ex-dividend June 25, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ZBH Valuation vs Medical Devices Median

Median of 151 stocks
MetricZBHMedical Devices medianvs median
P/E24.0426.8010% below
P/S ratio2.202.9826% below
Profit margin9.48%−1.69%11.2 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Zimmer Biomet Holdings, Inc. (ZBH) carries a market capitalisation of $18.71B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 17,000.

The 52-week range on file runs from $79.12 to $106.88. The most recent close on file for ZBH is $98.07, dated September 4, 2026. That is −$0.85 (−0.86%) against the previous close. The latest close sits 23.95% above that 52-week low.

Financial Health

In fiscal 2025, Zimmer Biomet Holdings, Inc. reported revenue of $8.23B. That is +7.20% against the prior fiscal year, when revenue was $7.68B. The same year closed with net income of $705.10M. That is −21.98% against the prior fiscal year. The reported profit margin is 9.48%. That is 11.2 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 4.08.

Across the 4 fiscal years on file, revenue moves from $6.94B in 2022 to $8.23B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 24.04. That is 10.3% below the Medical Devices median of 26.8. On forward earnings the ratio is 10.82. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.62. The price-to-sales ratio is 2.2. On price-to-sales that is 26.13% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.47. Annualized volatility over the trailing 10 years is 28.72%. The trailing one-year price return is −5.40%. Across 10 years the annualized return works out at −1.64%.

Growth & Income

Shareholders receive a dividend, yielding 0.97% on the latest price. That is 0.4 percentage points below the Medical Devices median yield of 1.38%. At the indicated rate that is $0.96 a share a year. The ex-dividend date on file is September 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $0.48 a share. The year before, 2025, totalled $0.96 a share.

Across the complete calendar years on file, 2019 returned +45.37% and 2021 returned −17.02%. Of the 9 complete calendar years on file, 4 finished higher. So far in 2026 the price is +9.65%.

Peer Comparison

Zimmer Biomet Holdings, Inc. (ZBH) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Zimmer Biomet Holdings, Inc. ZBH $18.71B 24.0
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Zimmer Biomet Holdings, Inc. trades at a P/E of 24.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Visit website →